Publicacions en què col·labora amb Alfonso Muriel García (33)

2024

  1. (, 10.2139/ssrn.4579870)

    Frontiers in Immunology

  2. Author Correction: Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer (Nature Medicine, (2023), 29, 7, (1738-1749), 10.1038/s41591-023-02407-3)

    Nature Medicine

  3. CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis

    Frontiers in Immunology, Vol. 15

2023

  1. A Risk Assessment Tool for Predicting Fragility Fractures in People with HIV: Derivation and Internal Validation of the FRESIA Model

    Journal of Bone and Mineral Research, Vol. 38, Núm. 10, pp. 1443-1452

  2. Conventional versus extended-pulsed fidaxomicin dosing in patients at high risk of recurrence of Clostridioides difficile infection: a propensity score analysis

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 3, pp. 823-827

  3. Impact of COVID-19 on the Care of Patients with HIV Infection

    Journal of Clinical Medicine, Vol. 12, Núm. 12

  4. Metabolic-Related Outcomes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Adults With Human Immunodeficiency Virus (HIV): A Multicenter Prospective Cohort Study

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 76, Núm. 3, pp. e652-e660

  5. Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer

    Nature Medicine, Vol. 29, Núm. 7, pp. 1738-1749

  6. The Influence of Pre-Existing Immunity against Human Common Cold Coronaviruses on COVID-19 Susceptibility and Severity

    Microbiology Research, Vol. 14, Núm. 3, pp. 1364-1375

2022

  1. An Easy-to-Implement Risk Score for Targeted Hepatitis C Virus Testing in the General Population

    Microbiology spectrum, Vol. 10, Núm. 2, pp. e0228621

  2. Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens

    Frontiers in Immunology, Vol. 13

  3. Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV

    Frontiers in immunology, Vol. 13, pp. 873408

2021

  1. Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 8, pp. 372-382

  2. Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 238-243

  3. Hepatitis C and HIV combined screening in primary care: A cluster randomized trial

    Journal of Viral Hepatitis, Vol. 28, Núm. 2, pp. 345-352

  4. Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study

    Journal of the International AIDS Society, Vol. 24, Núm. 5

2020

  1. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

    The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573

  2. Pneumococcal vaccination in adult people living with HIV on suppressive antiretroviral therapy: a case–control study

    International Journal of STD and AIDS, Vol. 31, Núm. 2, pp. 174-182

2019

  1. Impact of a structured HIV testing program in a hospital emergency department and a primary care center

    PLoS ONE, Vol. 14, Núm. 8

  2. Outcome of an HIV education program for primary care providers: Screening and late diagnosis rates

    PLoS ONE, Vol. 14, Núm. 7